Infectious Disease · Yuma, AZ
NPI
1710916705
Since 2006
Specialty
Infectious Disease
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2281 W 24th St, Suite 11
Yuma, AZ, 85364
Phone (928) 314-3201
Groups this clinician bills Medicare through
Medicare paid, 2024
$273K
3,164 services
Medicare patients, 2024
648
Average age 76
Drug cost, 2024
$1.0M
964 prescriptions
Company payments, 2025
$20.6
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Engida B Alemu was code 99232 (hospital e&m - subsequent), 1,410 times for 372 patients. In total Engida B Alemu billed 3,164 services in 7 codes, and Medicare paid $273K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,410 | 372 | $60.15 | $85K |
| 99233 Hospital E&M - Subsequent | Facility | 603 | 263 | $90.59 | $55K |
| 99223 Hospital E&M - Initial | Facility | 590 | 495 | $132.28 | $78K |
| 99214 Office E&M - Established | Office | 449 | 242 | $95.78 | $43K |
| 99204 Office E&M - New | Office | 82 | 82 | $119.57 | $9,805 |
| 99222 Hospital E&M - Initial | Facility | 20 | 20 | $98.98 | $1,980 |
By year: 2022 $234K for 3,218 services; 2023 $235K for 2,857 services; 2024 $273K for 3,164 services.
Medicare prescription drug claims, 2024
In 2024, the drug Engida B Alemu prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 148 prescriptions and refills. In total Engida B Alemu wrote 964 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 148 | 148 | 15 | $616K |
| Cephalexin Generic | 113 | 139 | 35 | $2,419 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 92 | 104 | 20 | $1,052 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 55 | 67 | 34 | $1,286 |
| Vancomycin Hcl Generic | 42 | 42 | 12 | $4,495 |
| Metronidazole Generic | 34 | 36 | 22 | $690 |
| Fluconazole Generic | 30 | 42 | 14 | $1,198 |
| Levofloxacin Generic | 27 | 29 | 18 | $220 |
| Tivicay Dolutegravir Sodium | 27 | 27 | Under 11 | $64K |
| Descovy Emtricitabine/Tenofov Alafenam | 27 | 27 | Under 11 | $59K |
| Ceftazidime Generic | 25 | 25 | Under 11 | $4,816 |
| Ertapenem Ertapenem Sodium | 25 | 25 | Under 11 | $10K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 23 | 25 | 16 | $568 |
| Doxycycline Monohydrate Generic | 22 | 34 | Under 11 | $669 |
| Cefepime Hcl Generic | 20 | 20 | Under 11 | $4,438 |
Brand drugs: 328 claims; generic drugs: 636 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Engida B Alemu $20.6 ($20.6 in general payments such as food, travel and fees) from 1 company. The largest payer was Merck Sharp & Dohme LLC with $20.6.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $20.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.